Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (965)	9/21/1999 10:02:00 PM
From: OpusX	Read Replies (1) \| Respond to of 5582

I'm in. Count me as another long. ...now to move some off my shelves :) Robert

To: out_of_the_loop who wrote (965)	9/21/1999 10:40:00 PM
From: Scott	Read Replies (1) \| Respond to of 5582

It makes sense that one would want to apply zinc to any area that can be infected by a cold virus. This means Zicam in the nose, and some form of zinc in the throat. Shouldn't the products be used together, to block more of the entry points? I used Zicam last week (cold lasted 3.5 days), and each time I used it, I would end up swallowing some, after sniffing it back (if I had a clear nostril at the time). Does this have any effect in the throat or sinuses, perhaps negating the need for zinc lozenges? Another question - do any other viruses infect via the ICAM attack? Does Zicam block them as well? I'm thinking of STDs, or even AIDS. Sorry if this has been brought up before. Thanks

To: out_of_the_loop who wrote (965)	9/21/1999 10:43:00 PM
From: Mad2	Read Replies (1) \| Respond to of 5582

Howard what are you saying? If QGLY claimes it and if QGLY advertizes it then I accept it. Secondly I don't question the studies having been cited by you and Dan and other GUMM supporters. Your suggestion that my answer is a bs question indicates that you would like to reduce the issues to some technical discussion about studies and reports. Do you really belive that GUMM's sucess in the market will hinge on these issues. GUMM and their stock price won't be determined by these studies. It will be determined by the by the same issues that sell other consumer products. Consumer friendliness, efficacy and marketing. As with Cold Ease I assume ZICAM is effective in reducing the duration of the common cold.....As does cold ease by the way which has been my experience. Thus will GUMM's marketing be better? Does it rate as a friendlier consumer product. To the first I don't know, but its likely to be costly. To the second the answer is no. Your showing your true colors Howard. Wither that or you not as smart as I assume you are. Mad2